Contact HealthDay
Tel: 203.855.1400 or E-mail

News By Specialty

Allergy
Anesthesiology
Cardiology
Cosmetic Surgery
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Practice
Gastroenterology
Geriatrics
Hematology & Oncology
HIV & AIDS
Infectious Disease
Internal Medicine
Nephrology
Neurology
Nursing
OBGYN & Women's Health
Ophthalmology
Orthopedics
Otolaryngology
Pain Management
Pathology
Pediatrics
Pharmacy
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Follow us on:

    


e-Healthcare Leadership Awards


Immune Intervention Reduces β-Cell Death in Type 1 Diabetes
Improvement in C-peptide responses seen with teplizumab; associated with decreased β-cell death
This article is older than one year and is no longer available.

Copyright © 2013 HealthDay. All rights reserved.

May 30, 2015

Archive Search

By Keyword:
By Category:
By Topic:

Related Articles

AMA: Physicians Driving the Slowing of Health Care Costs

Insulin Resistance Not Linked to Post-Adolescent Acne

RYGB Cuts Markers of Oxidative Stress in Subcutaneous Tissue

Metformin Linked With Lower Open-Angle Glaucoma Risk

Vegan Diet Tied to Weight Loss, Improved Neuropathy in DM

Post-CABG Predictors of Stroke Identified for Diabetes Patients